Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 6093903, 8 pages
https://doi.org/10.1155/2017/6093903
Research Article

Dimethyl Fumarate Induces Glutathione Recycling by Upregulation of Glutathione Reductase

1Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2) and Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
2Department of Neurology, Heinrich Heine Universität Düsseldorf, Düsseldorf, Germany

Correspondence should be addressed to Axel Methner; moc.liamg@renhtem.lexa

Received 15 June 2016; Revised 5 November 2016; Accepted 16 November 2016; Published 1 January 2017

Academic Editor: Albena Dinkova-Kostova

Copyright © 2017 Christina Hoffmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Compston and A. Coles, “Multiple sclerosis,” The Lancet, vol. 372, no. 9648, pp. 1502–1517, 2008. View at Publisher · View at Google Scholar
  2. R. E. Gonsette, “Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity,” Journal of the Neurological Sciences, vol. 274, no. 1-2, pp. 48–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K.-A. Nave and B. D. Trapp, “Axon-glial signaling and the glial support of axon function,” Annual Review of Neuroscience, vol. 31, pp. 535–561, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Kappos, R. Gold, D. H. Miller et al., “Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study,” The Lancet, vol. 372, no. 9648, pp. 1463–1472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. U. Mrowietz, J. C. Szepietowski, R. Loewe et al., “Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm®- and placebo-controlled trial (BRIDGE),” British Journal of Dermatology, 2016. View at Publisher · View at Google Scholar
  6. M. R. Yazdi and U. Mrowietz, “Fumaric acid esters,” Clinics in Dermatology, vol. 26, no. 5, pp. 522–526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Dibbert, B. Clement, T. Skak-Nielsen, U. Mrowietz, and M. Rostami-Yazdi, “Detection of fumarate-glutathione adducts in the portal vein blood of rats: Evidence for rapid dimethylfumarate metabolism,” Archives of Dermatological Research, vol. 305, no. 5, pp. 447–451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. H. R. Litjens, J. Burggraaf, E. Van Strijen et al., “Pharmacokinetics of oral fumarates in healthy subjects,” British Journal of Clinical Pharmacology, vol. 58, no. 4, pp. 429–432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Treumer, K. Zhu, R. Gläser, and U. Mrowietz, “Dimethylfumarate is a potent inducer of apoptosis in human T cells,” Journal of Investigative Dermatology, vol. 121, no. 6, pp. 1383–1388, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Vandermeeren, S. Janssens, H. Wouters et al., “Dimethylfumarate is an inhibitor of cytokine-induced nuclear translocation of NF-κB1, but not RelA in normal human dermal fibroblast cells,” Journal of Investigative Dermatology, vol. 116, no. 1, pp. 124–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. R. De Jong, A. C. Bezemer, T. P. L. Zomerdijk, T. van de Pouw-Kraan, T. H. M. Ottenhoff, and P. H. Nibbering, “Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate,” European Journal of Immunology, vol. 26, no. 9, pp. 2067–2074, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. T. J. Schmidt, M. Ak, and U. Mrowietz, “Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-L-cysteine—preparation of S-substituted thiosuccinic acid esters,” Bioorganic & Medicinal Chemistry, vol. 15, no. 1, pp. 333–342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Schmidt and R. Dringen, “Fumaric acid diesters deprive cultured primary astrocytes rapidly of glutathione,” Neurochemistry International, vol. 57, no. 4, pp. 460–467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. D. Held, E. R. Epp, S. Awad, and J. E. Biaglow, “Postirradiation sensitization of mammalian cells by the thiol-depleting agent dimethyl fumarate,” Radiation Research, vol. 127, no. 1, pp. 75–80, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. Dethlefsen, C. M. Lehman, J. E. Biaglow, and V. M. Peck, “Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells,” Radiation Research, vol. 114, no. 2, pp. 215–224, 1988. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Baird, D. Llères, S. Swift, and A. T. Dinkova-Kostova, “Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 38, pp. 15259–15264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. L. E. Tebay, H. Robertson, S. T. Durant et al., “Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease,” Free Radical Biology and Medicine, vol. 88, pp. 108–146, 2015. View at Publisher · View at Google Scholar
  18. S. X. Lin, L. Lisi, C. Dello Russo et al., “The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1,” ASN Neuro, vol. 3, no. 2, pp. 75–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Linker, D.-H. Lee, S. Ryan et al., “Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway,” Brain, vol. 134, no. 3, pp. 678–692, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Albrecht, J. Lewerenz, S. Dittmer, R. Noack, P. Maher, and A. Methner, “Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target,” CNS & Neurological Disorders—Drug Targets, vol. 9, pp. 373–382, 2010. View at Google Scholar
  21. P. Albrecht, I. Bouchachia, N. Goebels et al., “Effects of dimethyl fumarate on neuroprotection and immunomodulation,” Journal of Neuroinflammation, vol. 9, article 163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Albrecht, I. Bouchachia, C. Zimmermann et al., “Effects of dimethyl fumarate on neuroprotection and immunomodulation,” Journal of Neuroinflammation, vol. 9, article 163, 2012. View at Publisher · View at Google Scholar
  23. C. J. Harvey, R. K. Thimmulappa, A. Singh et al., “Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress,” Free Radical Biology and Medicine, vol. 46, no. 4, pp. 443–453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. B. H. Morimoto and D. E. Koshland Jr., “Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line,” Neuron, vol. 5, no. 6, pp. 875–880, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. J. B. Davis and P. Maher, “Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line,” Brain Research, vol. 652, no. 1, pp. 169–173, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Lewerenz, P. Albrecht, M.-L. T. Tien et al., “Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro,” Journal of Neurochemistry, vol. 111, no. 2, pp. 332–343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. K. P. Rice, P. G. Penketh, K. Shyam, and A. C. Sartorelli, “Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine™ and BCNU,” Biochemical Pharmacology, vol. 69, no. 10, pp. 1463–1472, 2005. View at Publisher · View at Google Scholar · View at Scopus